1684 related articles for article (PubMed ID: 17943779)
1. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
2. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
4. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
5. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
6. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
7. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
8. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
9. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003212. PubMed ID: 28146296
[TBL] [Abstract][Full Text] [Related]
10. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
[TBL] [Abstract][Full Text] [Related]
12. Nasal high flow therapy for primary respiratory support in preterm infants.
Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
14. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
[TBL] [Abstract][Full Text] [Related]
15. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive high-frequency ventilation in newborn infants with respiratory distress.
Abdel-Latif ME; Tan O; Fiander M; Osborn DA
Cochrane Database Syst Rev; 2024 May; 5(5):CD012712. PubMed ID: 38695628
[TBL] [Abstract][Full Text] [Related]
17. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
[TBL] [Abstract][Full Text] [Related]
18. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2016 Jun; (6):CD001243. PubMed ID: 27315509
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]